Modest improvement of metabolic and behavioral deficits with long-term ambroxol treatment in a Pink1<sup>-/-</sup>SNCA<sup>A53T</sup> double mutant mouse model of Parkinson's disease. [PDF]
Franck L +10 more
europepmc +1 more source
Meta-analysis of the adjuvant treatment of COPD with Erchen Decoction. [PDF]
Gao X, Lv X, Dong W, Zhang L, Zuo J.
europepmc +1 more source
Exploring the long-term use of ambroxol in Gaucher disease type 2: insights from two pediatric cases. [PDF]
Aries C +7 more
europepmc +1 more source
Ambroxol confers neuroprotection against scopolamine-induced Alzheimer's-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2/JNK/GSK-3β signaling pathways. [PDF]
Ahmad W +4 more
europepmc +1 more source
Field survey on warnings to prevent drug abuse when selling over-the-counter drugs at drugstores. [PDF]
Nagashima K, Nasu H, Sekine Y.
europepmc +1 more source
Investigating drug-liposome interactions using liposomal electrokinetic chromatography. [PDF]
Šimonová A +3 more
europepmc +1 more source
Ambroxol induces myeloma cell death by inhibiting autophagy. [PDF]
Hattori Y +12 more
europepmc +1 more source
Acute eosinophilic pneumonia induced by amiodarone: a rare case with early-onset. [PDF]
Zhang L, Zhang T, Zhou M, Chen J.
europepmc +1 more source
Development of a rapid method for the simultaneous determination of aminophylline, doxofylline, bromhexine, and ambroxol by HPLC. [PDF]
Meng X, Feng Y, Chen F, Shi M, Fang B.
europepmc +1 more source
Retrospective analysis of adverse drug reaction patterns from the national monitoring system in a tertiary care hospital in China (2019-2024). [PDF]
Yuan XL +6 more
europepmc +1 more source

